LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
MCF7	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1235	4760	4119	1.1556	1.1736
MCF7	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	1235	4880	4356	1.1202	1.1289
MCF7	Seliciclib	0.04	uM	LJP5	3	J06	72	hr	1235	4855	4326	1.1222	1.1316
MCF7	Seliciclib	0.12	uM	LJP5	1	J05	72	hr	1235	4144	4119	1.0060	1.0069
MCF7	Seliciclib	0.12	uM	LJP5	2	J05	72	hr	1235	4195	4356	0.9630	0.9589
MCF7	Seliciclib	0.12	uM	LJP5	3	J05	72	hr	1235	5017	4326	1.1596	1.1707
MCF7	Seliciclib	0.37	uM	LJP5	1	J04	72	hr	1235	3699	4119	0.8980	0.8799
MCF7	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	1235	3684	4356	0.8457	0.8239
MCF7	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	1235	3984	4326	0.9209	0.9109
MCF7	Seliciclib	1.11	uM	LJP5	1	J03	72	hr	1235	3327	4119	0.8077	0.7686
MCF7	Seliciclib	1.11	uM	LJP5	2	J03	72	hr	1235	3514	4356	0.8067	0.7771
MCF7	Seliciclib	1.11	uM	LJP5	3	J03	72	hr	1235	3740	4326	0.8645	0.8452
MCF7	Seliciclib	3.33	uM	LJP5	1	J02	72	hr	1235	2738	4119	0.6647	0.5810
MCF7	Seliciclib	3.33	uM	LJP5	2	J02	72	hr	1235	3270	4356	0.7506	0.7081
MCF7	Seliciclib	3.33	uM	LJP5	3	J02	72	hr	1235	3295	4326	0.7616	0.7204
MCF7	Seliciclib	10	uM	LJP5	1	J01	72	hr	1235	734	4119	0.1782	-0.2589
MCF7	Seliciclib	10	uM	LJP5	2	J01	72	hr	1235	687	4356	0.1577	-0.2759
MCF7	Seliciclib	10	uM	LJP5	3	J01	72	hr	1235	697	4326	0.1611	-0.2713
MCF7	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1235	3316	3974	0.8344	0.7963
MCF7	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1235	3573	4070	0.8778	0.8541
MCF7	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1235	3793	4126	0.9192	0.9055
MCF7	AT-7519	0.12	uM	LJP6	1	K05	72	hr	1235	1412	3974	0.3553	0.0825
MCF7	AT-7519	0.12	uM	LJP6	2	K05	72	hr	1235	1407	4070	0.3457	0.0786
MCF7	AT-7519	0.12	uM	LJP6	3	K05	72	hr	1235	1370	4126	0.3320	0.0612
MCF7	AT-7519	0.37	uM	LJP6	1	K04	72	hr	1235	890	3974	0.2240	-0.1768

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)